Cytek Biosciences, Inc. (CTKB) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$40.38M | -96.8% |
| 2024 | -$20.52M | +26.3% |
| 2023 | -$27.84M | -1443.5% |
| 2022 | -$1.80M | -119.7% |
| 2021 | $9.16M | -33.0% |
| 2020 | $13.66M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$40.38M | -96.8% |
| 2024 | -$20.52M | +26.3% |
| 2023 | -$27.84M | -1443.5% |
| 2022 | -$1.80M | -119.7% |
| 2021 | $9.16M | -33.0% |
| 2020 | $13.66M | — |